Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  2002-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1164/AJRCCM.165.7.2106014PMID 11934726
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased nuclear factor κB activation in critically ill patients who die

  2000cited by this paper
• Increased nuclear factor kappa B activation in critically ill patients who die.

  2000cited by this paper
• A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin.

  2000cited by this paper
• An Historical Review of Glucocorticoid Treatment in Sepsis. Disease Pathophysiology and the Design of Treatment Investigation

  1999cited by this paper
• Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways.

  1999cited by this paper
• Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment.

  1998cited by this paper
• A Dual Mechanism Mediates Repression of NF-κB Activity by Glucocorticoids

  1998cited by this paper
• Nuclear Integration of Glucocorticoid Receptor and Nuclear Factor-κB Signaling by CREB-binding Protein and Steroid Receptor Coactivator-1*

  1998cited by this paper
• Duration of glucocorticoid treatment and outcome in sepsis: is the right drug used the wrong way?

  1998cited by this paper
• Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF‐κB‐dependent transcription

  1998cited by this paper
• A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids.

  1998cited by this paper
• Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial.

  1998cited by this paper
• Role of NFkappaB in the mortality of sepsis.

  1997cited by this paper
• Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

  1997cited by this paper
• NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules.

  1997cited by this paper
• Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids.

  1996cited by this paper
• NF-kappa B: ten years after.

  1996influential reference
• NF-κB: Ten Years After

  1996cited by this paper
• A novel action of IL-13: induction of diminished monocyte glucocorticoid receptor-binding affinity.

  1996cited by this paper
• The acute respiratory distress syndrome: Definitions, severity and clinical outcome An analysis of 101 clinical investigations

  1996cited by this paper
• Molecular mechanisms of anti‐inflammatory action of glucocorticoids

  1996cited by this paper
• Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids.

  1996influential reference
• Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids

  1995cited by this paper
• Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.

  1995cited by this paper
• Interleukin (IL)-10 Inhibits Nuclear Factor B (NFB) Activation in Human Monocytes

  1995cited by this paper
• Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time.

  1995cited by this paper
• Clinical Investigations in Critical CarePersistent Elevation of Inflammatory Cytokines Predicts a Poor Outcome in ARDS: Plasma IL-1β and IL-6 Levels Are Consistent and Efficient Predictors of Outcome Over Time

  1995cited by this paper
• Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms.

  1995influential reference
• Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock.

  1995cited by this paper
• Glucocorticoid resistance in asthma.

  1995cited by this paper
• Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS.

  1995cited by this paper
• Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma.

  1995cited by this paper
• The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

  1994cited by this paper
• Effect of glucocorticoid receptor (GR) blockade on endotoxemia in rats.

  1994cited by this paper
• Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy.

  1994cited by this paper
• Syndromes of Glucocorticoid Resistance

  1993cited by this paper
• Mechanical ventilation. American College of Chest Physicians' Consensus Conference.

  1993cited by this paper
• Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids.

  1993cited by this paper
• Changes of pulmonary glucocorticoid receptor and phospholipase A2 in sheep with acute lung injury after high dose endotoxin infusion.

  1993cited by this paper
• The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.

  1993cited by this paper
• Cortisol receptor resistance: the variability of its clinical presentation and response to treatment.

  1992cited by this paper
• Cortisol resistance in acquired immunodeficiency syndrome.

  1992cited by this paper
• Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma.

  1991cited by this paper
• Glucocorticoid receptor characteristics in monocytes of patients with corticosteroid-resistant bronchial asthma.

  1991cited by this paper
• Contribution of cortisol deficiency to septic shock.

  1991cited by this paper
• An expanded definition of the adult respiratory distress syndrome.

  1988influential reference
• Comparative studies on adrenal cortical function and cortisol metabolism in healthy adults and in patients with shock due to infection.

  1958cited by this paper

• Methylprednisolone Protects Human Pancreatic Beta Cells From Inflammation-induced Damage

  2025cites this paper
• Síndrome de dificultad respiratoria aguda

  2025cites this paper
• Sindrome da distress respiratorio acuto

  2025cites this paper
• Glucocorticoid receptor alpha: origins and functions of the master regulator of homeostatic corrections in health and critical illness

  2025cites this paper
• Glucocorticoids and GRα Signaling in Critical Illness: Phase-Specific Homeostatic Corrections Across Systems

  2025cites this paper
• Factors Influencing Glucocorticoid Treatment Response: Mechanism-Based Strategies to Overcome Glucocorticoid Resistance and Restore GRα Function

  2025cites this paper
• Early C-reactive protein reduction predicts survival in COVID-19 severe pneumonia treated with glucocorticoids

  2025cites this paper
• Limitations in the Design of Critical Care Studies and Suggestions for Future Research Directions

  2025cites this paper
• The cholinergic drug galantamine ameliorates acute and subacute peripheral and brain manifestations of acute respiratory distress syndrome in mice

  2025cites this paper
• The cholinergic drug galantamine ameliorates acute and subacute peripheral and brain manifestations of acute respiratory distress syndrome in mice

  2025cites this paper
• An appraisal of lung computer tomography in very early anti-inflammatory treatment of two different ovine ARDS phenotypes

  2024cites this paper
• Clinical outcomes of corticosteroid administration for acute respiratory distress syndrome in adults based on meta-analyses and trial sequential analysis

  2024cites this paper
• Endogenous serum glucocorticoid concentrations, steroidogenic enzyme activity, and 90-day mortality in patients hospitalized with COVID-19: an observational cohort study

  2024cites this paper
• Syndrome de détresse respiratoire aiguë

  2024cites this paper
• Critical illness-related corticosteroid insufficiency (CIRCI) - an overview of pathogenesis, clinical presentation and management

  2024cites this paper
• Cytokine signalling in formation of neutrophil extracellular traps: Implications for health and diseases.

  2024cites this paper
• Glucocorticoid use in acute respiratory failure from pulmonary causes and association with early changes in the systemic host immune response

  2024cites this paper
• Positive effects of methylprednisolone continuous infusion in treatment of hospitalized patients with COVID-19 associated bacterial pneumonia

  2023cites this paper
• Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter—A Critical Review and Viewpoints

  2023cites this paper
• Application of anti-inflammatory treatment in two different ovine Acute Respiratory Distress Syndrome injury models: a preclinical randomized intervention study

  2023cites this paper
• Glucocorticoid Therapy in COVID-19

  2023cites this paper
• The role of protein corona on nanodrugs for organ-targeting and its prospects of application.

  2023cites this paper
• A Cross-Sectional Survey Study on the Diagnosis and Management of Critical Illness-Induced Corticosteroid Insufficiency in Saudi Arabia

  2023cites this paper
• Microbiome-Scale Analysis of Aerosol Facemask Contamination during Nebulization Therapy in the Hospital.

  2023cites this paper
• Tight Junctions, the Epithelial Barrier, and Toll-like Receptor-4 During Lung Injury

  2022cites this paper
• Efficacy of initial high- versus low-dose intravenous corticosteroid therapy in patients with acute exacerbation of idiopathic interstitial pneumonia: A nationwide observational study

  2022cites this paper
• Precision medicine for corticotherapy in COVID-19

  2022cites this paper
• Mode of methylprednisolone administration and its influence on ARDS dynamics in treatment of hospitalized COVID‑19 patients

  2022cites this paper
• Decreased cardiovascular risk factors and inflammation with remission of type 2 diabetes in adults with obesity using a high protein diet: Randomized control trial

  2022cites this paper
• Review COVID-19 and Fungal infections: a double debacle and

  2022influential citation
• COVID-19 and corticosteroids: a narrative review

  2022cites this paper
• A Case Report for Using Methylprednisolone for Severe ARDS Caused by SARS-CoV-2 Delta Variant in a Pediatric Patient With Lennox-Gastaut Syndrome

  2022cites this paper
• “MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale

  2022cites this paper
• Review COVID-19 and Fungal infections: a double debacle and

  2022influential citation
• COVID-19 and Fungal infections: a double debacle

  2022influential citation
• Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS

  2022cites this paper
• A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis

  2021cites this paper
• TCRM_A_313003 657..668

  2021influential citation
• Acute Neuroendocrine Profile in Predicting Outcomes in Severe Traumatic Brain Injury: A Study from a Tertiary Care Center in South India

  2021cites this paper
• Therapeutic Agents Rounding Up the Immunopathology of COVID-19

  2021influential citation
• Characteristics of Inflammatory Storm in BALF of Severe Pneumonia in Children

  2021cites this paper
• Prolonged Methylprednisolone Therapy in the Fibro-Proliferative Phase of Acute Respiratory Distress Syndrome

  2021cites this paper
• Decreased mortality in acute respiratory distress syndrome patients treated with corticosteroids: an updated meta-analysis of randomized clinical trials with trial sequential analysis

  2021cites this paper
• Hyperglycemia- and Hyperlipidemia-Induced Inflammation and Oxidative Stress through Human T Lymphocytes and Human Aortic Endothelial Cells (HAEC)

  2021cites this paper
• Characteristics of In ammatory Storm in BALF of Severe Pneumonia in Children: A Case Control Study

  2021cites this paper
• Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial

  2020cites this paper
• Hyperglycemia and Hyperlipidemia Induced Inflammation and Oxidative Stress in Human T Lymphocytes and Salutary Effects of ω- 3 Fatty Acid.

  2020cites this paper
• Corticosteroid Therapy of Patients in ICU with Coronavirus Disease 2019(COVID-19): A Single-center, Retrospective, Observational study

  2020cites this paper
• Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective

  2020influential citation
• General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections

  2020cites this paper
• Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS

  2020cites this paper
• Clinical and Scientific Rationale for the “MATH+” Hospital Treatment Protocol for COVID-19

  2020cites this paper
• Effectiveness of the Use of Dexamethasone in Treatment of Coronavirus Infections: A Systematic Review

  2020cites this paper
• Preadmission Corticosteroid Therapy and the Risk of Respiratory Failure in Adults Without HIV Presenting With Pneumocystis Pneumonia

  2020cites this paper
• Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: protocol of a randomized controlled trial

  2020cites this paper
• Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Alveolar Epithelial Type II Cells

  2020cites this paper
• Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)

  2020cites this paper
• Safety of drugs during previous and current coronavirus pandemics: Lessons for IBD

  2020cites this paper
• Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature

  2020cites this paper
• Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment

  2020cites this paper
• ¿QUÉ HEMOS APRENDIDO DE FALLA RESPIRATORIA CATASTRÓFICA?

  2019cites this paper
• Severe Trauma and Sepsis

  2019influential citation
• Corticosteroids in Acute Lung Injury: The Dilemma Continues

  2019cites this paper
• Novel Insights into Anti-inflammatory Therapy in Sepsis-Induced ARDS

  2019cites this paper
• Steroids in pediatric acute respiratory distress syndrome.

  2019cites this paper
• An Exploratory Reanalysis of the Randomized Trial on Efficacy of Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome*

  2018cites this paper
• Study of the Effects of Combined Therapy with Sodium Valproate, Peg-interferon and Corticosteroid on Proviral Load of HTLV-1 and the Expression of Rel-A, Creb and IL-1 Genes in Patients with HTLV-1 associated Myelopathy/Tropical Spastic Paraparesis

  2018cites this paper
• Steroids to Soften the Blow in Persistent Acute Respiratory Distress Syndrome.

  2018cites this paper
• Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS

  2018cites this paper
• The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions

  2018cites this paper
• Changes in 11β-Hydroxysteroid Dehydrogenase and Glucocorticoid Receptor Expression in Kawasaki Disease

  2017cites this paper
• Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome*

  2017cites this paper
• Indinavir Plus Methylprednisolone Ameliorates Experimental Acute Lung Injury In Vitro and In Vivo

  2017cites this paper
• Protective Effects of the Ethanol Extract of Viola tianshanica Maxim against Acute Lung Injury Induced by Lipopolysaccharides in Mice.

  2017cites this paper
• A review of associated controversies surrounding glucocorticoid use in veterinary emergency and critical care.

  2017cites this paper
• Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM)

  2017cites this paper
• Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us

  2016cites this paper
• Corticosteroids in treatment of aspiration-related acute respiratory distress syndrome: results of a retrospective cohort study

  2016cites this paper
• Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature

  2016cites this paper
• Eupatorium lindleyanum DC. flavonoids fraction attenuates lipopolysaccharide-induced acute lung injury in mice.

  2016cites this paper
• Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: yes

  2016cites this paper
• Recent Advancement on Current Trend in the Management of Endocrine Emergency in Critically Ill Patient

  2016cites this paper
• Cytokine Reduction in the Setting of an ARDS-Associated Inflammatory Response with Multiple Organ Failure

  2016influential citation
• Eupatorium lindleyanum DC. sesquiterpenes fraction attenuates lipopolysaccharide-induced acute lung injury in mice.

  2016cites this paper
• Corticosteroid therapy in refractory shock following cardiac arrest: a randomized, double-blind, placebo-controlled, trial

  2016cites this paper
• Possible role for anisodamine in organophosphate poisoning

  2016cites this paper
• The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: a retrospective propensity matched cohort study

  2016cites this paper
• The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness

  2016cites this paper
• Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness

  2016cites this paper
• Inhibition of endogenous glucocorticoid synthesis aggravates lung injury triggered by septic shock in rats

  2015cites this paper
• Adjunct Systemic Corticosteroid Therapy in Children With Community-Acquired Pneumonia in the Outpatient Setting.

  2015cites this paper
• Diffuse alveolar damage in nonresolving ARDS provides support for prolonged glucocorticoid treatment

  2015cites this paper
• Exaggerated plasma Interleukin 6, Interleukin 10, and Subsequent Development of Health Care–Associated Infections in Patients With Sepsis

  2015cites this paper
• Cyanidin-3-O-β-glucoside ameliorates lipopolysaccharide-induced acute lung injury by reducing TLR4 recruitment into lipid rafts.

  2014cites this paper
• Rabdosia japonica var. glaucocalyx Flavonoids Fraction Attenuates Lipopolysaccharide-Induced Acute Lung Injury in Mice

  2014cites this paper
• Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice.

  2014cites this paper
• Therapeutic effect of inhaled budesonide (Pulmicort® Turbuhaler) on the inflammatory response to one‐lung ventilation

  2014cites this paper
• Expression of IL-17A and IL-17F in lipopolysaccharide-induced acute lung injury and the counteraction of anisodamine or methylprednisolone.

  2014cites this paper
• Peluang Baru Pemberian Kortikosteroid Sebagai Terapi pada Kasus Preeklampsia

  2014cites this paper
• Predictors of Response to Corticosteroid Treatment in Patients with Early Acute Respiratory Distress Syndrome: Results of a Pilot Study

  2014cites this paper